Skip to main content
APADAZ 325 mg/1, 8.16 mg/1 tablet by Zevra Therapeutics, Inc.
APADAZ, 325 mg/1, 8.16 mg/1, tablet Available on prescription only. Listed by Zevra Therapeutics, Inc..
Prescription only Schedule II

APADAZ

Benzhydrocodone and Acetaminophen

Listed by Zevra Therapeutics, Inc.

Strength
325 mg/1, 8.16 mg/1
Form
Tablet
Route
Oral
Federally controlled substance — Schedule II. Medicines in this category carry extra legal requirements on prescribing, dispensing and refills because of their potential for dependence or misuse. They cannot be supplied without a valid prescription.

What it contains

  • Benzhydrocodone Hydrochloride 325 mg/1
  • Acetaminophen 8.16 mg/1

This is a combination product. It is not interchangeable with a single-ingredient medicine containing only one of these.

FDA record

Dosage form Tablet
Route Oral
Approval route NDA — original brand approval
NDC code 70040-0189
FDA application NDA208653
RxNorm concept 2001358
Package sizes listed 1
Marketed since February 2018

Other products containing Benzhydrocodone

See all

Same active ingredient, different manufacturer, strength or form. Products matching on both ingredient and strength are usually interchangeable — but confirm before switching, especially with modified-release forms.

APADAZ

Benzhydrocodone and Acetaminophen

Strength
325 mg/1, 6.12 mg/1
Form
Tablet
Rx only Schedule II

Zevra Therapeutics, Inc.

Not stocked by us — reference only

APADAZ

Benzhydrocodone and Acetaminophen

Strength
325 mg/1, 4.08 mg/1
Form
Tablet
Rx only Schedule II

Zevra Therapeutics, Inc.

Not stocked by us — reference only

Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.